ANIX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases...

Stats
Dagens volum	115 773
Gjennomsnittsvolum	121 793
Markedsverdi	93.79M
EPS	$0 ( 2024-03-21 )
Neste inntjeningsdato	( $-0.110 ) 2024-06-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.65
ATR14	$0.0300 (1.02%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Catelani Michael	Buy	1 189	Common Stock
2024-04-09	Titterton Lewis H Jr	Buy	15 009	Common Stock
2024-03-15	Baskies Arnold M	Buy	10 000	Common Stock
2024-03-15	Kumar Amit	Buy	30 000	Common Stock
2024-01-12	Baskies Arnold M	Buy	25 000	Employee Stock Option (Right to Buy)

INSIDER POWER
61.41
Last 100 transactions
Buy: 11 627 548 \| Sell: 3 491 117

Volum Korrelasjon

Lang: -0.19 (neutral)

Kort: 0.45 (neutral)

Signal:(48.856) Neutral

Anixa Biosciences Inc Korrelasjon

10 Mest positive korrelasjoner
REKR	0.924
BDSX	0.905
IONS	0.899
SYPR	0.894
LTRX	0.892
UTME	0.89
PEV	0.882
GYRO	0.879
WKME	0.879
SOFO	0.878

10 Mest negative korrelasjoner
CFMS	-0.898
PAE	-0.891
VSEC	-0.89
QNST	-0.888
PWP	-0.885
COUP	-0.881
NATI	-0.881
TTD	-0.879
FCYIX	-0.879
TWNK	-0.879

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Anixa Biosciences Inc Korrelasjon - Valuta/Råvare

-0.68
( moderate negative )

-0.50
( neutral )

0.00
( neutral )

-0.54
( weak negative )

0.58
( weak )

Anixa Biosciences Inc Økonomi

Annual	2023
Omsetning:	$210 000
Bruttogevinst:	$49 000.00 (23.33 %)
EPS:	$-0.320

FY	2023
Omsetning:	$210 000
Bruttogevinst:	$49 000.00 (23.33 %)
EPS:	$-0.320

FY	2022
Omsetning:	$2.47B
Bruttogevinst:	$2.47B (100.00 %)
EPS:	$-0.440

FY	2021
Omsetning:	$512 500
Bruttogevinst:	$127 498 (24.88 %)
EPS:	$-0.450

Financial Reports:

No articles found.

Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.